A weekly 4‐methylpyrazole treatment attenuates the development of non‐obese metabolic dysfunction‐associated steatotic liver disease (MASLD) in male mice: Role of JNK.
Saved in:
| Title: | A weekly 4‐methylpyrazole treatment attenuates the development of non‐obese metabolic dysfunction‐associated steatotic liver disease (MASLD) in male mice: Role of JNK. |
|---|---|
| Authors: | Burger, Katharina1 (AUTHOR), Jung, Finn1 (AUTHOR), Staltner, Raphaela1 (AUTHOR), Csarmann, Katja1 (AUTHOR), Schweiger, Kerstin1 (AUTHOR), Brandt, Annette1 (AUTHOR), Baumann, Anja1 (AUTHOR), Scholda, Julia2 (AUTHOR), Kopp, Florian2 (AUTHOR), Bergheim, Ina1 (AUTHOR) ina.bergheim@univie.ac.at |
| Source: | European Journal of Clinical Investigation. Jan2025, Vol. 55 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 00142972 |
|---|---|
| DOI: | 10.1111/eci.14320 |
